Meet The Professors: Pancreatic Cancer Edition, 2016 - Video 38Cachexia associated with pancreatic cancer
1:07 minutes.
TRANSCRIPTION:
DR LOVE: Margaret, what about the issue of cachexia? Anything new and exciting there? DR TEMPERO: First of all, it’s important to understand that every patient who presents, even though they may look completely normal to you, is actually cachexic. We have been able to show that by doing so as muscle measurements and showing that they’re already losing muscle mass. DR LOVE: And is this like a paraneoplastic syndrome? DR TEMPERO: Most likely. Most likely. DR LOVE: Do we know what it is, or — DR TEMPERO: No. No. But it’s a great area for research. And there’s a lot of interest now in agents that will prevent progression or even reverse cachexia. And I think this is going to be important to integrate into therapy, because as you might imagine, the more fit a patient is, the better they’ll tolerate any type of treatment that we might want to deliver. So if we could really get this under better control from the get-go, I think patients would do better in the long run. They’d tolerate therapy better. It would just be a better picture overall. And I think it would add to improved survival. |